FC
BMY icon

Fairscale Capital’s Bristol-Myers Squibb BMY Stock Holding History

Fairscale Capital’s Portfolio BMY Stock Details BMY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$133K Hold
2,197
– – 0.09% 123
2025
Q4 		$119K Sell
2,197
-225
-9% -$10.8K 0.08% 131
2025
Q3 		$109K Hold
2,422
– – 0.08% 135
2025
Q2 		$106K Hold
2,422
– – 0.08% 135
2025
Q1 		$148K Hold
2,422
– – 0.13% 91
2024
Q4 		$137K Hold
2,422
– – 0.12% 97
2024
Q3 		$125K Hold
2,422
– – 0.11% 106
2024
Q2 		$99.8K Buy
+2,422
New +$108K 0.09% 118

Other funds holding BMY

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Fairscale Capital's BMY Position: Q1 2026 in Review

Fairscale Capital held its Bristol-Myers Squibb (BMY) position steady in Q1 2026 at 2,197 shares worth $133K. The position accounts for 0.09% of the portfolio, ranked #123.

Fairscale Capital first reported a position in BMY in Q2 2024 and has held it in 8 quarters since. The position peaked at $148K in Q1 2025. 2,519 funds tracked by Wall St. Rank hold BMY as of Q1 2026.

  • Fairscale Capital held 2,197 shares of Bristol-Myers Squibb worth $133K as of Q1 2026.
  • Fairscale Capital left its Bristol-Myers Squibb share count unchanged in Q1 2026.
  • Bristol-Myers Squibb made up 0.09% of Fairscale Capital's portfolio in Q1 2026, its #123 holding.
  • Fairscale Capital first reported a position in Bristol-Myers Squibb in Q2 2024 and has held it in 8 quarters since.
  • Fairscale Capital's Bristol-Myers Squibb position peaked at $148K in Q1 2025.
  • 2,519 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q1 2026.

Based on Fairscale Capital's 13F filing for Q1 2026, filed 11 May 2026.